AstraZeneca Upgrades Outlook as Cancers Drug Sales Jump 0 25.07.2024 09:50 The Wall Street Journal AstraZeneca raised its full-year guidance after second-quarter earnings topped forecasts, boosted by a 15% rise in revenue at its oncology buisness. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
